Clara Pérez‐Mañá

2.8k total citations
100 papers, 2.0k citations indexed

About

Clara Pérez‐Mañá is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Clara Pérez‐Mañá has authored 100 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Toxicology, 30 papers in Pharmacology and 29 papers in Clinical Psychology. Recurrent topics in Clara Pérez‐Mañá's work include Forensic Toxicology and Drug Analysis (40 papers), Psychedelics and Drug Studies (27 papers) and Cannabis and Cannabinoid Research (22 papers). Clara Pérez‐Mañá is often cited by papers focused on Forensic Toxicology and Drug Analysis (40 papers), Psychedelics and Drug Studies (27 papers) and Cannabis and Cannabinoid Research (22 papers). Clara Pérez‐Mañá collaborates with scholars based in Spain, Italy and United States. Clara Pérez‐Mañá's co-authors include Magı́ Farré, Esther Papaseit, Marta Torrens, Rafael de la Torre, Dolors Capellà, Mitona Pujadas, Rosa Ventura, Eulàlia Olesti, Xavier Vidal and Xavier Matabosch and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Clara Pérez‐Mañá

97 papers receiving 1.9k citations

Peers

Clara Pérez‐Mañá
Clara Pérez‐Mañá
Citations per year, relative to Clara Pérez‐Mañá Clara Pérez‐Mañá (= 1×) peers Mitona Pujadas

Countries citing papers authored by Clara Pérez‐Mañá

Since Specialization
Citations

This map shows the geographic impact of Clara Pérez‐Mañá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Pérez‐Mañá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Pérez‐Mañá more than expected).

Fields of papers citing papers by Clara Pérez‐Mañá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Pérez‐Mañá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Pérez‐Mañá. The network helps show where Clara Pérez‐Mañá may publish in the future.

Co-authorship network of co-authors of Clara Pérez‐Mañá

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Pérez‐Mañá. A scholar is included among the top collaborators of Clara Pérez‐Mañá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Pérez‐Mañá. Clara Pérez‐Mañá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montané, Eva, Yolanda Sanz, Clara Pérez‐Mañá, et al.. (2024). Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital. Frontiers in Pharmacology. 15. 1427772–1427772.
2.
Maida, Nunzia La, Maria Concetta Rotolo, Simona Pichini, et al.. (2023). GC–MS/MS Determination of Synthetic Cathinones: 4-Chloromethcathinone, N-Ethyl Pentedrone, and N-Ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study. International Journal of Molecular Sciences. 24(11). 9387–9387. 7 indexed citations
3.
Poyatos, Lourdes, Esther Papaseit, Clara Pérez‐Mañá, et al.. (2023). Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH. Metabolites. 13(4). 468–468. 5 indexed citations
4.
Pellegrini, Manuela, Emilia Marchei, Roberta Pacifici, et al.. (2022). New Psychoactive Substances Consumption in Opioid-Use Disorder Patients. Biology. 11(5). 645–645. 5 indexed citations
5.
Poyatos, Lourdes, Esther Papaseit, Clara Pérez‐Mañá, et al.. (2022). Abuse Potential of Cathinones in Humans: A Systematic Review. Journal of Clinical Medicine. 11(4). 1004–1004. 15 indexed citations
6.
Soto, Lucía Martínez de, Nunzia La Maida, Esther Papaseit, et al.. (2021). Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study. Frontiers in Pharmacology. 12. 705643–705643. 11 indexed citations
7.
Giacani, Lorenzo, et al.. (2021). Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study. EBioMedicine. 65. 103281–103281. 23 indexed citations
8.
Papaseit, Esther, Clara Pérez‐Mañá, Marta Torrens, et al.. (2020). MDMA interactions with pharmaceuticals and drugs of abuse. Expert Opinion on Drug Metabolism & Toxicology. 16(5). 357–369. 18 indexed citations
9.
Pichini, Simona, Sara Malaca, Massimo Gottardi, et al.. (2020). UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis. Talanta. 223(Pt 2). 121772–121772. 22 indexed citations
10.
Felip, Eudald, Clara Pérez‐Mañá, Mireia Margelí Vila, et al.. (2019). New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib – A Case Report. Breast Care. 15(5). 548–552. 6 indexed citations
11.
Pérez‐Mañá, Clara, Esther Papaseit, Francina Fonseca, et al.. (2019). Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers. Frontiers in Pharmacology. 10. 131–131. 5 indexed citations
12.
Papaseit, Esther, Marta Torrens, Clara Pérez‐Mañá, Roberto Muga, & Magı́ Farré. (2018). Key interindividual determinants in MDMA pharmacodynamics. Expert Opinion on Drug Metabolism & Toxicology. 14(2). 183–195. 11 indexed citations
13.
Papaseit, Esther, et al.. (2018). Cannabinoids: from pot to lab. International Journal of Medical Sciences. 15(12). 1286–1295. 58 indexed citations
14.
Olesti, Eulàlia, Mitona Pujadas, Esther Papaseit, et al.. (2016). GC–MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics. Journal of Analytical Toxicology. 41(2). 100–106. 30 indexed citations
15.
Farré, Magı́, Clara Pérez‐Mañá, Esther Papaseit, et al.. (2015). Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart. European Neuropsychopharmacology. 25(10). 1637–1649. 20 indexed citations
16.
Pérez‐Mañá, Clara, Magı́ Farré, Mitona Pujadas, et al.. (2015). Ethanol induces hydroxytyrosol formation in humans. Pharmacological Research. 95-96. 27–33. 23 indexed citations
17.
Yubero‐Lahoz, Samanta, Ricardo Pardo, Magı́ Farré, et al.. (2012). Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug. Drug Metabolism and Pharmacokinetics. 27(6). 605–613. 14 indexed citations
18.
Matabosch, Xavier, Óscar J. Pozo, Clara Pérez‐Mañá, et al.. (2012). Identification of budesonide metabolites in human urine after oral administration. Analytical and Bioanalytical Chemistry. 404(2). 325–340. 37 indexed citations
19.
Yubero‐Lahoz, Samanta, Ricardo Pardo, Magı́ Farré, et al.. (2011). Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. Clinical Pharmacokinetics. 50(5). 319–329. 22 indexed citations
20.
Pérez‐Mañá, Clara, Xavier Castells, Xavier Vidal, Miguel Casas, & Dolors Capellà. (2010). Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials. Journal of Substance Abuse Treatment. 40(2). 109–122. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026